Logo image of NBVA.CA

NUBEVA TECHNOLOGIES LTD (NBVA.CA) Stock Fundamental Analysis

Canada - TSX-V:NBVA - CA67021Y1097 - Common Stock

0.08 CAD
-0.01 (-11.11%)
Last: 9/10/2025, 7:00:00 PM
Fundamental Rating

3

Overall NBVA gets a fundamental rating of 3 out of 10. We evaluated NBVA against 63 industry peers in the Software industry. NBVA has a great financial health rating, but its profitability evaluates not so good. NBVA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NBVA has reported negative net income.
In the past year NBVA had a positive cash flow from operations.
NBVA had negative earnings in each of the past 5 years.
In the past 5 years NBVA always reported negative operating cash flow.
NBVA.CA Yearly Net Income VS EBIT VS OCF VS FCFNBVA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -1M -2M -3M -4M

1.2 Ratios

NBVA's Return On Assets of 1.12% is in line compared to the rest of the industry. NBVA outperforms 58.73% of its industry peers.
Looking at the Return On Equity, with a value of 1.18%, NBVA is in line with its industry, outperforming 58.73% of the companies in the same industry.
Industry RankSector Rank
ROA 1.12%
ROE 1.18%
ROIC N/A
ROA(3y)-38.75%
ROA(5y)-61.47%
ROE(3y)-42.42%
ROE(5y)-87.72%
ROIC(3y)N/A
ROIC(5y)N/A
NBVA.CA Yearly ROA, ROE, ROICNBVA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

NBVA's Profit Margin of 6.09% is fine compared to the rest of the industry. NBVA outperforms 79.37% of its industry peers.
NBVA does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 6.09%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NBVA.CA Yearly Profit, Operating, Gross MarginsNBVA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K -2K

More info and screens

8

2. Health

2.1 Basic Checks

NBVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
NBVA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NBVA has more shares outstanding
Compared to 1 year ago, NBVA has a worse debt to assets ratio.
NBVA.CA Yearly Shares OutstandingNBVA.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
NBVA.CA Yearly Total Debt VS Total AssetsNBVA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

An Altman-Z score of 7.82 indicates that NBVA is not in any danger for bankruptcy at the moment.
NBVA has a better Altman-Z score (7.82) than 80.95% of its industry peers.
The Debt to FCF ratio of NBVA is 0.55, which is an excellent value as it means it would take NBVA, only 0.55 years of fcf income to pay off all of its debts.
NBVA's Debt to FCF ratio of 0.55 is amongst the best of the industry. NBVA outperforms 80.95% of its industry peers.
NBVA has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of NBVA (0.00) is better than 84.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.55
Altman-Z 7.82
ROIC/WACCN/A
WACC11.2%
NBVA.CA Yearly LT Debt VS Equity VS FCFNBVA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

2.3 Liquidity

NBVA has a Current Ratio of 21.26. This indicates that NBVA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 21.26, NBVA belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.
NBVA has a Quick Ratio of 21.26. This indicates that NBVA is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 21.26, NBVA belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 21.26
Quick Ratio 21.26
NBVA.CA Yearly Current Assets VS Current LiabilitesNBVA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

3

3. Growth

3.1 Past

NBVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 105.94%, which is quite impressive.
NBVA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -74.89%.
Measured over the past years, NBVA shows a quite strong growth in Revenue. The Revenue has been growing by 16.15% on average per year.
EPS 1Y (TTM)105.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.83%
Revenue 1Y (TTM)-74.89%
Revenue growth 3Y-3.07%
Revenue growth 5Y16.15%
Sales Q2Q%-57.79%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NBVA.CA Yearly Revenue VS EstimatesNBVA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
NBVA.CA Yearly EPS VS EstimatesNBVA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 -0.01 -0.02 -0.03 -0.04

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
NBVA.CA Price Earnings VS Forward Price EarningsNBVA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as NBVA.
Industry RankSector Rank
P/FCF 157.12
EV/EBITDA N/A
NBVA.CA Per share dataNBVA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NBVA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NUBEVA TECHNOLOGIES LTD

TSX-V:NBVA (9/10/2025, 7:00:00 PM)

0.08

-0.01 (-11.11%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-26 2025-08-26
Earnings (Next)09-29 2025-09-29
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners25.48%
Ins Owner ChangeN/A
Market Cap5.61M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.32
P/FCF 157.12
P/OCF 119.23
P/B 1.23
P/tB 1.23
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.64%
OCF(TTM)0
OCFY0.84%
SpS0.01
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.12%
ROE 1.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 6.09%
GM N/A
FCFM 4.02%
ROA(3y)-38.75%
ROA(5y)-61.47%
ROE(3y)-42.42%
ROE(5y)-87.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.55
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 65.98%
Current Ratio 21.26
Quick Ratio 21.26
Altman-Z 7.82
F-Score6
WACC11.2%
ROIC/WACCN/A
Cap/Depr(3y)305.57%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.77%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)105.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-74.89%
Revenue growth 3Y-3.07%
Revenue growth 5Y16.15%
Sales Q2Q%-57.79%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y101.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y102.64%
OCF growth 3YN/A
OCF growth 5YN/A